Physician profile
Keith Damerau
NPI 1558302349
$2,659.10
in general payments reported to CMS, 2019-2025
27 companies · $56.25 in 2025
The $56.25 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $266 · 2021: $189 · 2022: $1,127 · 2023: $232 · 2024: $387 · 2025: $56.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $654.13 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $291.44 | 2019-2024 | Mounjaro, Jardiance |
| Abbvie INC. | $290.43 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.16 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $143.13 | 2019-2022 | |
| Astellas Pharma US INC | $123.57 | 2019-2022 | |
| Corcept Therapeutics | $118.96 | 2022 | |
| Medtronic, INC. | $111.09 | 2022-2025 | Minimed 780g, Abre |
| Janssen Pharmaceuticals, INC | $108.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $74.91 | 2021-2024 | Breztri |
| Pfizer INC. | $63.64 | 2019-2024 | |
| Philips North America LLC | $57.90 | 2022 | |
| Acadia Pharmaceuticals INC | $54.73 | 2022 | |
| Exact Sciences Corporation | $45.33 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $39.51 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $37.57 | 2019-2022 | |
| Allergan, INC. | $32.50 | 2020 | |
| Tandem Diabetes Care, INC. | $31.30 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Bausch Health US, LLC | $29.00 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.68 | 2022 | |
| Xeris Pharmaceuticals, INC. | $26.52 | 2022 | |
| Amgen INC. | $25.74 | 2019 | |
| Sequel Med Tech, LLC | $18.60 | 2025 | Twiist |
| Insulet Corporation | $18.04 | 2024 | Omnipod |
| Collegium Pharmaceutical, INC. | $14.36 | 2020 | |
| Amarin Pharma, INC. | $12.90 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Damerau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.